Efficacy and safety of eptinezumab as migraine preventive therapy: A systematic review and meta-analysis

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Journal of Applied Pharmaceutical Science

Abbreviated Title: J App Pharm Sc

ISSN (Electronic): 22313354

Publication date Created: 2022

Publication date (Electronic): 2022

Article

DOI: 10.7324/JAPS.2023.130202

SO-VID: b1ac1b4c-4df9-4ee3-9774-4d4e1b516542

License:

All content is freely available without charge to users or their institutions. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission of the publisher or the author. Articles published in the journal are distributed under a http://creativecommons.org/licenses/by/4.0/.

History

ScienceOpen disciplines: Physical chemistry,Pharmacology & Pharmaceutical medicine

Data availability:

ScienceOpen disciplines: Physical chemistry, Pharmacology & Pharmaceutical medicine

Comments

Comment on this article

scite_